-- Agreement with Health House for supply of Satipharm CBD Gelpell(R) Capsules throughout Australia, New Zealand and Asia
Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSXV: HVT; OTCQX: HRVOF), through it's wholly-owned subsidiary Satipharm Ltd. ("Satipharm") today announced that it has entered into an agreement to become a supplier to the renowned medicinal cannabis wholesale & distribution business, Health House International Pty Ltd ("Health House").
Under the terms of the agreement, Harvest One will supply Health House with Satipharm CBD 50mg Gelpell(R) capsules . The product will continue its availability in Australia, while expanding distribution to New Zealand and Asia where and when legal.
Under the agreement, Health House will purchase in bulk and distribute Satipharm's medicinal cannabis products to their existing network of pharmacies while also supporting healthcare professionals with Satipharm product information. Health House International are one of the major wholesalers to Australian pharmacies for medicinal cannabis. In May 2017 they imported one of the first legal international medicinal cannabis shipments into Australia.
Satipharm CEO Jonathan Hartshorn
